Mark Golick, Pharm.D.

Mark Golick is a seasoned pharmacist and healthcare professional with over 40 years of experience spanning pharmacy practice, hospital settings, and the pharmaceutical industry. Inspired at a young age by a family friend pharmacist and guided by early mentors, Mark began his pharmacy journey at 15 in a local drugstore. He earned his Bachelor’s degree in Pharmacy from Northeastern University in 1982, beginning his career at the Boston VA, where he developed a strong foundation in patient care and hospital pharmacy operations.

After gaining valuable experience in hospital pharmacy, Mark transitioned to the pharmaceutical industry, joining Upjohn, where he spent 17 years and contributed to pioneering the Medical Science Liaison (MSL) role. Throughout his career, he has worked across multiple therapeutic areas, including cardiology, thrombosis, neurology, psychiatry, endocrinology, and women’s health, developing expertise in scientific communication, medical education, and health outcomes research. His commitment to advancing healthcare knowledge led him to earn a Doctor of Pharmacy from Massachusetts College of Pharmacy in 2001 and a certification in Health Economics and Outcomes Research from the University of Washington in 2014.

Mark’s most recent industry role was as Director of Managed Care Liaison at Neurocrine Biosciences, where he led strategic engagement with managed care organizations, mentored teams, and facilitated collaborations with key opinion leaders. In this position, he combined his clinical knowledge and health economic expertise to support evidence-based decision-making, improve market access, and guide research initiatives. His career reflects a balance of analytical insight, creative strategy, and emotionally intelligent leadership, enabling him to foster strong professional relationships and deliver impactful results.

Currently, Mark is a self-employed consultant, leveraging his extensive experience to support liaison initiatives and team development for pharmaceutical organizations. He has led high-performing teams, hired and mentored professionals, and contributed to the field through published research. What Mark finds most rewarding is the opportunity to educate and collaborate with healthcare leaders, ensuring that patients receive the most effective, research-based treatments. His lifelong dedication to pharmacy and healthcare continues to drive innovation, mentorship, and excellence in the industry.

• Doctor of Pharmacy (Pharm.D.), Massachusetts College of Pharmacy and Health Sciences, 2001
• Bachelor of Science in Pharmacy, Northeastern University, 1982
• Certification in Health Economics & Outcomes Research, University of Washington, 2014

• Health Economics and Outcomes Research Certification

• ASHP (American Society of Health-System Pharmacists)
• AMCP (Academy of Managed Care Pharmacy)
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research)

• Mentoring pharmacy students and early-career professionals; advising on managed care and outcomes research projects.

·      Boklage S, Preblick R, Yaldo A, Golick M, Pocoski J,  “Retrospective Database Analysis of Frequency and Costs of Relapses Among Multiple Sclerosis Patients.”  Value in Health 14(3) · May 2011

·      Joish V, Muccino D, Golick M, Minai O, “Physician Monitoring of Pulmonary Arterial Hypertension Subjects: Results From a Large U.S. Health Insurance Claims Database.” Chest142 (4_MeetingAbstracts): 814A · October 2012

·      Morton R, Chepke C, Dhanda R, Bron M, Golick M, “Real-World Long-Term Outcomes with Valbenazine in Adults with Tardive Dyskinesia” Presented at AMCP Nexus, Denver 2021